Preclinical evaluation of antihyperglycemic activity of Clerodendron infortunatum leaf against streptozotocin-induced diabetic rats

Diabetes Therapy

Volumn 2, Issue 2, 2011, Pages 92-100

  Das, Sudipta ^a   Bhattacharya, Sanjib ^b   Prasanna, Angelene ^c   Kumar, R B Suresh ^c   Pramanik, Goutam ^d   Haldar, Pallab K ^c  

^a BOSE INSTITUTE   (India)

^b Bengal School of Technology   (India)

^c JADAVPUR UNIVERSITY   (India)

^d Durgapur 713212   (India)

Author keywords

antihyperglycemic; antioxidant; Clerodendron infortunatum; glibenclamide; streptozotocin

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ANTIDIABETIC AGENT; ASPARTATE AMINOTRANSFERASE; CATALASE; CHOLESTEROL; CLERODENDRON INFORTUNATUM EXTRACT; GLIBENCLAMIDE; GLUCOSE; GLUTATHIONE; METHANOL; PLANT EXTRACT; PROTEIN; STREPTOZOCIN; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CLERODENDRON INFORTUNATUM; CONTROLLED STUDY; DIABETES MELLITUS; DOSE RESPONSE; DRUG MECHANISM; DRUG SCREENING; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; LIPID PEROXIDATION; MALE; NONHUMAN; PLANT LEAF; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; STREPTOZOCIN DIABETES; VERBENACEAE;

EID: 79955942938     PISSN: 18696953     EISSN: 18696961     Source Type: Journal    
DOI: 10.1007/s13300-010-0019-z     Document Type: Article

References (30)

1. Piedrola G, Novo E, Escober F, Garciacia-Robles R. White blood cell count and insulin resistance in patients with coronary artery disease. Ann Endocrinol. 2001; 62: 7-10.
2. Weidmann P, Boehlen LM, de Courten M. Pathogenesis and treatment of hypertension associated with diabetes mellitus. Am Heart J. 1993; 125: 1498-1513.
3. Nadkarni KM, Nadkarni AK. Indian Materia Medica. Bombay: Popular Publication; 2002.
4. Sreevastava N. Clerodendron and healthcare. J Med Aroma Plant Sci Biotech. 2007; 1: 142-150.
5. Chopra RN, Nayar SL, Chopra IC. Glossary of Indian Medicinal Plants. New Delhi: Publication and Information Directorate, CSIR; 1992.
6. Akihisa T, Matsubara Y, Ghosh P, Thakur S, Tamura T, Matsumoto T. Sterols of some Clerodendrum species (Verbenaceae): occurrence of the 24 alpha-and 24 beta-epimers of 24-ethylsterols lacking a delta 25-bond. Steroids. 1989; 53: 625-638.
7. Sinha NK, Seth K, Pandey VB, Dasgupta B, Shah AH. Flavonoids from the flowers of Clerodendron infortunatum. Planta Med. 1981; 42: 296-298.
8. Ahmed F, Shahid IZ, Biswas UK, Roy BA, Das AK, Choudhuri MSK. Anti-inflammatory, antinociceptive, and neuropharmacological activities of Clerodendron viscosum. Pharm Biol. 2007; 45: 587-593.
9. Sannigrahi S, Mazumder UK, Pal D, Mishra SL. Hepatoprotective potential of methanol extract of Clerodendrum infortunatum Linn. against CCl4 induced hepatotoxicity in rats. Phcog Mag. 2009; 5: 394-399.
10. Das S, Haldar PK, Pramanik G, Suresh RB. Evaluation of anti-inflammatory activity of Clerodendron infortunatum Linn. extract in rats. Global J Pharmacol. 2010; 4: 48-50.
11. Pellegrino MP, Broca C, Gross R, et al. Development of a new model of type II diabetes in adult rats administered with streptozotocin and nicotinamide. Diabetes. 1998; 47: 224-229.
12. Ewart RBL, Kornfeld S, Kipnis DM. Effect of lectins on hormone release from isolated rat islets of Langerhans. Diabetes. 1975; 24, 705-714.
13. Panda SP, Haldar PK, Bera S, Adhikary S, Kandar CC. Antidiabetic and antioxidant activity of Swietenia mahagoni in streptozotocin-induced diabetic rats. Pharm Biol. 2010; 48: 974-979.
14. Fraga CG, Leibovitz BE, Toppel AL. Lipid peroxidation measured as TBARS in tissue characterization and comparison with homogenates and microsomes. Free Radic Biol Med. 1981; 4: 155-161.
15. Ellman GL. Tissue sulphydryl groups. Arch Biochem Biophys. 1959; 82: 70-77.
16. Sinha KA. Colorimetric assay of catalase. Annal Biochem. 1972; 47: 389-394.
17. Junod A, Lambert AE, Stauffacher W, Renold AE. Diabetogenic action of streptozotocin: relationship of dose to metabolic response. J Clin Invest. 1969; 48: 2129-2139.
18. Varva JJ, DeBoer C, Dietz A. Streptozotocin, a new antibacterial antibiotic. Antibiot Annu. 1959-1960; 7: 230-235.
19. Wright JR, Abraham C, Dickson BC, Yang H, Morrison CM. Streptozotocin dose response curve in tilapia, a glucose-responsive teleost fish. Gen Comp Endocrinol. 1999; 114: 431-440.
20. Frode TS, Medeiros YS. Animal models to test drugs with potential antidiabetic activity. J Ethnopharmacol. 2008; 115: 173-183.
21. Ghosh S, Suryawansi SA. Effect of Vinca rosea extracts in treatment of alloxan diabetes in male albino rats. Indian J Exp Biol. 2001; 39: 748-759.
22. Arvind K, Pradeep R, Deepa R, Mohan V. Diabetes and coronary artery diseases. Indian J Med Res. 2002; 116: 163-176.
23. Boynes JW. Role of oxidative stress in development of complication in diabetes. Diabetes. 1991; 40: 405-411.
24. Janero DR. Malondialdehyde and thiobarbituric acid reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Rad Biol Med. 1990; 9: 515-540.
25. Arias IM, Jakoby WB. Glutathione: Metabolisms and Functions. New York: Raven Press; 1976.
26. Loven D, Schedf H, Wilson H, et al. Effect of insulin and oral glutathione on glutathione level and superoxide dismutase activities in organs of rats with streptozotocin induced diabetes. Diabetes. 1986; 35: 503-507.
27. Venukumar MR, Latha MS. Antioxidant activity of Curculigo orchioides in carbon tetrachloride induced hepatopathy in rats. Indian J Clin Biochem. 2002; 17: 80-87.
28. Sabu MC, Kuttan R. Antidiabetic activity of Aegle marmelos and its relationship with its antioxidant properties. Indian J Physiol Pharmacol. 2004; 48: 81-88.
29. Thomann R, Rossinelli N, Keller U, et al. Differences in low-grade chronic inflammation and insulin resistance in women with previous gestational diabetes mellitus and women with polycystic ovary syndrome. Gynecol Endocrinol. 2008; 24: 199-206.
30. Pietta PG. Flavonoids as antioxidants. J Nat Prod. 2000; 63: 1035-1042.